197 related articles for article (PubMed ID: 33565520)
1. Transcatheter arterial chemoembolization (TACE) with iRGD peptide in rabbit VX2 liver tumor.
Liu X; Xie Y; Qi X; Xu K
J Cancer Res Ther; 2020; 16(7):1703-1709. PubMed ID: 33565520
[TBL] [Abstract][Full Text] [Related]
2. Transarterial Infusion of iRGD-Modified ZrO
Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
[TBL] [Abstract][Full Text] [Related]
5. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
6. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
[TBL] [Abstract][Full Text] [Related]
8. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo-Immuno-Embolization for the Treatment of Hepatocellular Carcinoma.
Kim H; Choi B; Mouli SK; Choi H; Harris KR; Kulik LM; Lewandowski RJ; Kim DH
Adv Healthc Mater; 2023 Oct; 12(26):e2300906. PubMed ID: 37163283
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
Yasui D; Yamane A; Itoh H; Kobayashi M; Kumita SI
PLoS One; 2020; 15(8):e0222553. PubMed ID: 32756561
[TBL] [Abstract][Full Text] [Related]
14. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.
Berz AM; Santana JG; Iseke S; Gross M; Pekurovsky V; Laage Gaupp F; Savic LJ; Borde T; Gottwald LA; Boustani AM; Gebauer B; Lin M; Zhang X; Schlachter T; Madoff DC; Chapiro J
J Vasc Interv Radiol; 2022 Jul; 33(7):764-774.e4. PubMed ID: 35346859
[TBL] [Abstract][Full Text] [Related]
15. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
16. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
18. Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor.
Tang H; Cao C; Zhang G; Sun Z
Drug Deliv; 2023 Dec; 30(1):1-16. PubMed ID: 36644796
[TBL] [Abstract][Full Text] [Related]
19. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
[TBL] [Abstract][Full Text] [Related]
20. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]